Suppr超能文献

无创通气与慢性高碳酸血症呼吸衰竭患者的撤机:一项随机多中心试验。

Noninvasive ventilation and weaning in patients with chronic hypercapnic respiratory failure: a randomized multicenter trial.

机构信息

Department of Medical Intensive Care, Rouen University Hospital, Rouen, France.

出版信息

Am J Respir Crit Care Med. 2011 Sep 15;184(6):672-9. doi: 10.1164/rccm.201101-0035OC.

Abstract

RATIONALE

The use of noninvasive ventilation (NIV) as an early weaning/extubation technique from mechanical ventilation remains controversial.

OBJECTIVES

To investigate NIV effectiveness as an early weaning/extubation technique in difficult-to-wean patients with chronic hypercapnic respiratory failure (CHRF).

METHODS

In 13 intensive care units, 208 patients with CHRF intubated for acute respiratory failure (ARF) who failed a first spontaneous breathing trial were randomly assigned to three groups: conventional invasive weaning group (n = 69), extubation followed by standard oxygen therapy (n = 70), or NIV (n = 69). NIV was permitted as rescue therapy for both non-NIV groups if postextubation ARF occurred. Primary endpoint was reintubation within 7 days after extubation. Secondary endpoints were: occurrence of postextubation ARF or death within 7 days after extubation, use of rescue postextubation NIV, weaning time, and patient outcomes.

MEASUREMENTS AND MAIN RESULTS

Reintubation rates were 30, 37, and 32% for invasive weaning, oxygen-therapy, and NIV groups, respectively (P = 0.654). Weaning failure rates, including postextubation ARF, were 54, 71, and 33%, respectively (P < 0.001). Rescue NIV success rates for invasive and oxygen-therapy groups were 45 and 58%, respectively (P = 0.386). By design, intubation duration was 1.5 days longer for the invasive group than in the two others. Apart from a longer weaning time in NIV than in invasive group (2.5 vs. 1.5 d; P = 0.033), no significant outcome difference was observed between groups.

CONCLUSIONS

No difference was found in the reintubation rate between the three weaning strategies. NIV decreases the intubation duration and may improve the weaning results in difficult-to-wean patients with CHRF by reducing the risk of postextubation ARF. The benefit of rescue NIV in these patients deserves confirmation.

摘要

背景

将无创通气(NIV)作为机械通气撤机/拔管的早期技术仍存在争议。

目的

研究 NIV 作为慢性高碳酸血症性呼吸衰竭(CHRF)患者撤机/拔管困难患者的早期撤机/拔管技术的有效性。

方法

在 13 个重症监护病房中,208 例因急性呼吸衰竭(ARF)而插管的 CHRF 患者在首次自主呼吸试验失败后被随机分为三组:常规有创撤机组(n=69)、拔管后给予标准氧疗(n=70)或 NIV 组(n=69)。如果发生拔管后 ARF,非 NIV 两组均允许使用 NIV 作为抢救治疗。主要终点是拔管后 7 天内再插管。次要终点是:拔管后 7 天内发生 ARF 或死亡、使用拔管后 NIV 抢救、撤机时间和患者结局。

测量和主要结果

有创撤机、氧疗和 NIV 组的再插管率分别为 30%、37%和 32%(P=0.654)。撤机失败率,包括拔管后 ARF,分别为 54%、71%和 33%(P<0.001)。有创和氧疗组的抢救性 NIV 成功率分别为 45%和 58%(P=0.386)。根据设计,有创组的插管时间比其他两组长 1.5 天。除了 NIV 组的撤机时间比有创组长 2.5 天(1.5 天;P=0.033)外,三组间无显著的结局差异。

结论

三种撤机策略之间的再插管率无差异。NIV 可减少拔管后 ARF 的风险,从而缩短 CHRF 患者的插管时间,并可能改善撤机结果。在这些患者中,抢救性 NIV 的益处需要进一步证实。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验